Synergistia Details: NCBI 649775, gram-negative or unknown [class]
| Synergistia| Synergistia Jumas-Bilak et al. 2009
Anaerobic Bacteria: Many bacteria within the class Synergistia are anaerobic, meaning they thrive in environments with little to no oxygen. The anaerobic conditions of the gut make it a suitable habitat for these bacteria.
Gut Microbiota: Some members of the class Synergistia have been identified in the human gut microbiota. The gut microbiota is a complex community of microorganisms that plays a crucial role in various physiological functions, including digestion, metabolism, and immune system regulation.
Metabolic Functions: Bacteria within the class Synergistia are involved in various metabolic processes, including the fermentation of complex organic compounds. This fermentation can result in the production of short-chain fatty acids (SCFAs) and other metabolites.
Associations with Human Health: While specific health impacts of Synergistia are not well-documented, the gut microbiota, in general, has been linked to human health. The gut microbiota is believed to influence processes such as nutrient absorption, immune system function, and protection against pathogenic bacteria.
Disease Associations: Some studies have explored associations between the abundance or composition of Synergistetes bacteria and certain health conditions. However, the specific role of Synergistia in these associations and whether they play a direct causative role in diseases are areas of ongoing research.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
- Immune Epitope Database
- The NCBI taxonomy database
- UniProt
- Immune Epitope Taxonomy Database (IEDB)
- AI Engines For more Details: Perplexity Kagi Labs You
 Statistics
|
NCBI | Data Punk | End Products Produced |
Lab Reporting
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Desired Levels Suggestions for Synergistia
- Frequency - how often do samples show this bacteria
- UD - An alternative statistical algorithm (which factors in the frequency)
- Kaltoft-Moldrup Heuristic Using uploaded data
- Lab Low and High are calculated using the formula that most labs use: Mean - 2 Standard Deviation to Mean + 2 Standard Deviation
| Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Labs | 1.94 | 9 | 5570 | 0 | 2160 | 364.3 | 36 | 916.1 | 0 | 478 | 0 %ile | 100 %ile | ||
| biomesight | 70.54 | 0 | 70 | 10 | 140 | 0 | 5127 | 300.7 | 60 | 2462.6 | 0 | 160 | 0 %ile | 90.8 %ile |
| thorne | 100 | 7 | 129 | 0 | 104 | 42 | 34 | 31.8 | 8 | 60 | 0 %ile | 100 %ile | ||
| thryve | 40.79 | 0 | 23 | 1 | 4026 | 0 | 4833 | 484.1 | 42 | 2218.6 | 2 | 214 | 0 %ile | 97.3 %ile |
| ubiome | 29.78 | 0 | 54 | 20 | 87678 | 0 | 22584 | 2741.1 | 281 | 10124 | 0 | 2315 | 0 %ile | 100 %ile |
External Reference Ranges for Synergistia
| Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
|---|---|---|---|---|
| Thorne (20/80%ile) | 23.51 | 90.45 | 0.0024 | 0.009 |
Statistic by Lab Source for Synergistia
| Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
|---|---|---|---|---|---|
| AmericanGut | 6.667 % | 0.108 % | % | 1.0 | 15 |
| BiomeSight | 76.457 % | 0.027 % | 0.213 % | 2257.0 | 2952 |
| BiomeSightRdp | 62.5 % | 0.009 % | 0.017 % | 20.0 | 32 |
| bugspeak | 100 % | 0.005 % | % | 1.0 | 1 |
| CerbaLab | 100 % | 0.017 % | 0.004 % | 3.0 | 3 |
| CosmosId | 3.125 % | 0.188 % | % | 1.0 | 32 |
| custom | 6.557 % | 0.008 % | 0.012 % | 4.0 | 61 |
| es-xenogene | 34.483 % | 0.009 % | 0.01 % | 10.0 | 29 |
| Medivere | 100 % | 0.031 % | 0.036 % | 7.0 | 7 |
| Microba | 7.143 % | 0.284 % | 0.385 % | 2.0 | 28 |
| Microba1 | 100 % | 0.19 % | % | 1.0 | 1 |
| SequentiaBiotech | 2.778 % | 0.043 % | % | 1.0 | 36 |
| Thorne | 83.871 % | 0.002 % | 0.002 % | 78.0 | 93 |
| Thryve | 39.278 % | 0.047 % | 0.211 % | 544.0 | 1385 |
| Tiny | 100 % | 0.001 % | % | 1.0 | 1 |
| uBiome | 29.798 % | 0.274 % | 1.01 % | 236.0 | 792 |
|
|
To see medical conditions associated you may be logged in
And display level must be raised above public.
I would like to know what can change the quality that I have
- If I want to know that a substance also changes, then I just click on it
- If I want to know which study this information comes from, then I just clink in increases or decreases
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.